Pharmanutra S.p.A. (PHN.MI)

EUR 54.8

(1.86%)

Operating Income Summary of Pharmanutra S.p.A.

Pharmanutra S.p.A.'s latest annual operating income in 2023 was 23.36 Million EUR , down -2.62% from previous year.
Pharmanutra S.p.A.'s latest quarterly operating income in 2024 Q2 was 10.4 Million EUR , up 154.76% from previous quarter.
Pharmanutra S.p.A. reported an annual operating income of 23.04 Million EUR in 2022, up 23.27% from previous year.
Pharmanutra S.p.A. reported an annual operating income of 18.69 Million EUR in 2021, up 40.23% from previous year.
Pharmanutra S.p.A. reported a quarterly operating income of 10.4 Million EUR for 2024 Q2, up 154.76% from previous quarter.
Pharmanutra S.p.A. reported a quarterly operating income of 2.91 Million EUR for 2023 Q4, down -36.14% from previous quarter.

Annual Operating Income Chart of Pharmanutra S.p.A. (2023 - 2015)

Historical Annual Operating Income of Pharmanutra S.p.A. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	23.36 Million EUR	-2.62%
2022	23.04 Million EUR	23.27%
2021	18.69 Million EUR	40.23%
2020	13.32 Million EUR	8.6%
2019	12.27 Million EUR	3.0%
2018	11.91 Million EUR	34.52%
2017	8.85 Million EUR	43.3%
2016	6.18 Million EUR	44.7%
2015	4.27 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	4.08 Million EUR	40.14%
2024 Q2	10.4 Million EUR	154.76%
2023 Q4	2.91 Million EUR	-36.14%
2023 FY	22.43 Million EUR	-2.62%
2023 Q1	6.96 Million EUR	41.66%
2023 Q2	6.23 Million EUR	-10.54%
2023 Q3	4.56 Million EUR	-26.76%
2022 FY	23.04 Million EUR	23.27%
2022 Q4	4.91 Million EUR	-21.95%
2022 Q3	6.3 Million EUR	-7.99%
2022 Q2	6.84 Million EUR	37.7%
2022 Q1	4.97 Million EUR	34.37%
2021 Q4	3.7 Million EUR	-26.94%
2021 Q3	5.06 Million EUR	-17.48%
2021 FY	18.69 Million EUR	40.23%
2021 Q1	3.53 Million EUR	25.22%
2021 Q2	6.13 Million EUR	73.66%
2020 Q4	2.82 Million EUR	35.07%
2020 FY	13.32 Million EUR	8.6%
2020 Q1	2.65 Million EUR	-31.99%
2020 Q2	5.86 Million EUR	121.05%
2020 Q3	2.09 Million EUR	-64.33%
2019 Q3	2.55 Million EUR	-14.65%
2019 Q4	3.89 Million EUR	52.44%
2019 FY	12.27 Million EUR	3.0%
2019 Q1	2.99 Million EUR	-0.69%
2019 Q2	2.99 Million EUR	0.0%
2018 Q1	2.56 Million EUR	13.68%
2018 FY	11.91 Million EUR	34.52%
2018 Q4	3.01 Million EUR	0.0%
2018 Q3	3.01 Million EUR	17.8%
2018 Q2	2.56 Million EUR	0.0%
2017 FY	8.85 Million EUR	43.3%
2017 Q1	2.14 Million EUR	49.48%
2017 Q2	2.14 Million EUR	0.0%
2017 Q3	2.25 Million EUR	4.91%
2017 Q4	2.25 Million EUR	0.0%
2016 Q1	1.65 Million EUR	0.0%
2016 Q2	1.65 Million EUR	0.0%
2016 Q3	1.43 Million EUR	-13.29%
2016 Q4	1.43 Million EUR	0.0%
2016 FY	6.18 Million EUR	44.7%
2015 FY	4.27 Million EUR	0.0%

Peer Operating Income Comparison of Pharmanutra S.p.A.

Name	Operating Income	Operating Income Difference